NEW YORK – Universal genetic testing could identify more cancer patients with pathogenic risk variants, potentially changing treatment approaches for some, a new analysis has found.
NEW YORK – Universal genetic testing could identify more cancer patients with pathogenic risk variants, potentially changing treatment approaches for some, a new analysis has found.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.